Dr James Smith
James completed his PhD at the University of Birmingham with a focus on mesenchymal stem cells and the extracellular matrix. He undertook post-doctoral training at the University of Nottingham developing automated manufacture technologies for human pluripotent stem cells, and was later appointed as a senior research fellow, using CRISPR gene editing and hiPSCs as tools to investigate cardiovascular disease. James set up his group at UEA in 2019.
Terri joins the lab following her MSci with First Class Honours in Biochemistry at UEA. Her PhD project is investigating intercellular signalling between cardiac and bone marrow populations.